Skip to main content

Table 1 Baseline characteristics of the different allocation groups

From: Effect of lifestyle or metformin interventions before IVF/ICSI treatment on infertile women with overweight/obese and insulin resistance: a factorial design randomised controlled pilot trial

 

Group A

(n = 17)

Group B

(n = 18)

Group C

(n = 19)

Group D

(n = 18)

Age — years

31(30–34)

29(26.75–33)

31(27–33)

29(27–31.25)

Weight — kg

69.80(63.80–71.30)

65.75(64.28–68.75)

67.20(64.40–73.10)

68.65(64.38–73.10)

BMI — kg/m2

27.27(26.68–30.30)

26.66(25.98–28.00)

27.38(26.16–29.30)

28.35(26.42–29.27)

Waist circumference — cm

93.00(88.50–97.00)

92.00(86.25–96.25)

91.50(87.50–97.50)

95.00(90.00–97.00)

Hip circumference — cm

103.00(98.50–106.50)

100.00(98.00–103.00)

102.00(100.00–104.25)

103.00(98.00–107.00)

Duration of Infertility — years

3(2–6)

3(2–5)

3(2–5)

3(2–4)

AMH— ng/ml

1.84(1.35–4.09)

2.87(1.63–5.15)

3.42(2.1–4.84)

4.25(2.58–6.25)

AFC—n

16(12.50–38.50)

19(11–30)

25(19–30)

27.5(18.25–30.50)

HOMA value before intervention

3.67(3.05–4.74)

3.57(3.16–4.94)

3.85(3.40–4.10)

3.48(3.06–4.23)

  1. For continuous variables median (interquartile ranges, IQR) is presented
  2. BMI Body Mass Index, AMH Anti-Mullerian Hormone, AFC Antral Follicle Counting, HOMA Homeostasis Model Assessment
  3. Group A: simple lifestyle intervention, Group B: simple metformin intervention, Group C: lifestyle + metformin intervention, Group D: no intervention